Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study).

No abstract is available for this paper.

• Publication year

  1999

• Venue

  AIDS (London)

• Publication date

  1999-05-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00002030-199905070-00001PMID 10357371
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Predictors of long‐term response to protease inhibitor therapy in a cohort of HIV‐infected patients

  1998cited by this paper
• Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation

  1998cited by this paper
• Rate of HIV‐1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen

  1998cited by this paper
• Activity of the soft gelatin formulation of saquinavir in combination therapy in antiretroviral‐naive patients

  1998cited by this paper
• Selecting the optimum dose for a new soft gelatin capsule formulation of saquinavir. NV15107 Study Group.

  1998cited by this paper
• Protease inhibitors do not increase the CD4+ cell count in HIV-uninfected individuals.

  1998cited by this paper
• Mathematical Modeling of the Interrelationship of CD4 Lymphocyte Count and Viral Load Changes Induced by the Protease Inhibitor Indinavir

  1998cited by this paper
• Nucleoside Analog 1592U89 and Human Immunodeficiency Virus Protease Inhibitor 141W94 Are Synergistic In Vitro

  1998cited by this paper
• Alternative multidrug regimen provides improved suppression of HIV‐1 replication over triple therapy

  1998cited by this paper
• Plasma Viral Load, CD4+ Cell Counts, and HIV-1 Production by Cells

  1996cited by this paper
• CD4+ lymphocyte count variations in HIV-negative subjects treated with zidovudine.

  1996cited by this paper
• Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

  1995cited by this paper

• Selective decline of intact HIV reservoirs during the first decade of ART followed by stabilization in memory T cell subsets

  2025cites this paper
• Self-Emulsifying Oral Lipid Drug Delivery Systems: Advances and Challenges

  2019cites this paper
• Synthetic routes and structure-activity relationships (SAR) of anti-HIV agents: A key review.

  2019cites this paper
• Recomendations from GESIDA/National AIDS plan on antiretroviral therapy in adult patients infected by the human immunodeficiency virus (October 2004)

  2015cites this paper
• LIPID BASED DRUG DELIVERY SYSTEM FOR ENHANCING ORAL BIOAVAILABILITY – A CONTEMPORARY

  2014cites this paper
• Formulation and In-vitro Evaluation of Matrix Controlled Lamivudine Tablets

  2013cites this paper
• Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS)

  2013cites this paper
• Indinavir

  2012cites this paper
• Antiretroviral Therapy for Human Immunodeficiency Virus Infection

  2010cites this paper
• The FDA Approved HIV-1 Protease Inhibitors for Treatment of HIV/AIDS

  2010cites this paper
• HIV-1 Can Persist in Aged Memory CD4+ T Lymphocytes With Minimal Signs of Evolution After 8.3 Years of Effective Highly Active Antiretroviral Therapy

  2009cites this paper
• The Cost-Effectiveness of Counseling Strategies to Improve Adherence to Highly Active Antiretroviral Therapy among Men Who Have Sex with Men

  2008cites this paper
• Cost-Effectiveness of HIV Screening in Patients Older than 55 Years of Age

  2008cites this paper
• Review: Immunologic Response to Protease Inhibitor-Based Highly Active Antiretroviral Therapy: A Review

  2007cites this paper
• Missing Data Imputation in Two Phase III Trials Treating HIV1 Infection

  2007cites this paper
• Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.

  2005cites this paper
• Screening for Human Immunodeficiency Virus in Adolescents and Adults

  2005cites this paper
• Recomendaciones de GESIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en pacientes adultos infectados por el VIH (octubre 2004)

  2004cites this paper
• Updated clinical pharmacologic considerations for HIV-1 protease inhibitors

  2004cites this paper
• The effectiveness of highly active antiretroviral therapy in HIV-infected patients.

  2004cites this paper
• Effects of highly active antiretroviral therapy among HIV-infected patients. Results from randomised and observational studies.

  2004cites this paper
• Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs.

  2004cites this paper
• Long-Term Efficacy and Safety of Twice-Daily Saquinavir Soft Gelatin Capsules (SGC), with or without Nelfinavir, and Three Times Daily Saquinavir-SGC, in Triple Combination Therapy for HIV Infection: 100-Week Follow-Up

  2003cites this paper
• Use of the Protease Inhibitor Saquinavir Hard Gel in Human Immunodeficiency Virus-infected Patients in the Early Period of Highly Active Antiretroviral Therapy: Does it Affect Long-term Treatment Outcome?

  2003cites this paper
• Pharmacokinetic and tolerability profile of twice‐daily saquinavir hard gelatin capsules and saquinavir soft gelatin capsules boosted with ritonavir in healthy volunteers

  2003cites this paper
• Recomendaciones de GESIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en pacientes adultos infectados por el virus de la inmunodeficiencia humana en el año 2002

  2002cites this paper
• Reconstitution of naive T cells during antiretroviral treatment of HIV-infected adults is dependent on age

  2002cites this paper
• [Recommendations of the Spanish AIDS Study Group (GESIDA) and the National Aids Plan (PNS) for antiretroviral treatment in adult patients with human immunodeficiency virus infection in 2002].

  2002cites this paper
• Systematic review and meta-analysis of evidence for increasing numbers of drugs in antiretroviral combination therapy

  2002cites this paper
• Long-term suppression of viral replication despite low plasma saquinavir concentrations in the CHEESE Study.

  2002cites this paper
• Human Immunodeficiency Virus

  2002cites this paper
• Efficacy and Safety of Twice-Daily versus Three-Times Daily Saquinavir Soft Gelatin Capsules as Part of Triple Combination Therapy for HIV-1 Infection

  2001cites this paper
• MIKADO: a multicentre, open‐label pilot study to evaluate the antiretroviral activity and safety of saquinavir with stavudine and zalcitabine

  2001cites this paper
• Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavir

  2001cites this paper
• Saquinavir and ritonavir pharmacokinetics following combined ritonavir and saquinavir (soft gelatin capsules) administration.

  2001cites this paper
• Durable HIV-1 Suppression with Indinavir after Failing Lamivudine-Containing Double Nucleoside Therapy: A Randomized Controlled Trial

  2001cites this paper
• [Value of saquinavir in antiretroviral treatment of adult HIV-1 infection in 2001].

  2001cites this paper
• Saquinavir Soft Gelatin Capsule

  2001cites this paper
• Low body weight and type of protease inhibitor predict discontinuation and treatment‐limiting adverse drug reactions among HIV‐infected patients starting a protease inhibitor regimen: consistent results from a randomized trial and an observational cohort

  2001cites this paper
• Pharmacology and clinical experience with saquinavir

  2001cites this paper
• Measuring the Effectiveness of Antiretroviral Agents

  2001cites this paper
• Clinical pharmacologic considerations for HIV-1 protease inhibitors

  2001cites this paper
• The interaction of saquinavir (soft gelatin capsule) with ketoconazole, erythromycin and rifampicin: comparison of the effect in healthy volunteers and in HIV-infected patients

  2001cites this paper
• Baseline CD4(+) cell count, not viral load, correlates with virologic suppression induced by potent antiretroviral therapy.

  2001cites this paper
• Baseline CD4+ Cell Count, Not Viral Load, Correlates With Virologic Suppression Induced by Potent Antiretroviral Therapy

  2001cites this paper
• Anti-Retroviral Therapy and Resistance to Anti-Retroviral Drugs

  2000cites this paper
• HIV and the immune system during highly active antiretroviral therapy

  2000cites this paper
• The Relevance of Pharmacologic Monitoring In HIV Disease

  2000cites this paper
• The Dominant Source of CD4+ and CD8+ T‐Cell Activation in HIV Infection Is Antigenic Stimulation

  2000cites this paper
• Increasing Treatment Adherence in the Correctional Setting: Current Efforts to Simplify Protease Inhibitor Dosing Regimens

  2000cites this paper
• Relative potencies of protease inhibitors

  2000cites this paper
• A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study

  2000cites this paper
• The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection.

  2000cites this paper
• T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART).

  2000cites this paper
• Saquinavir soft-gel capsule: an updated review of its use in the management of HIV infection.

  2000cites this paper
• Saquinavir Soft-Gel Capsule

  2000influential citation
• Randomised, Multicentre Phase III Study of Saquinavir plus Zidovudine plus Zalcitabine in Previously Untreated or Minimally Pretreated HIV-Infected Patients

  2000cites this paper
• Antiretroviral therapy of HIV-1 infection: established treatment strategies and new therapeutic options.

  2000cites this paper
• Safety and Pharmacokinetics of Once-Daily Regimens of Soft-Gel Capsule Saquinavir plus Minidose Ritonavir in Human Immunodeficiency Virus-Negative Adults

  2000cites this paper
• High-dose saquinavir plus ritonavir: long-term efficacy in HIV-positive protease inhibitor-experienced patients and predictors of virologic response.

  1999cites this paper
• Indinavir: a review of its use in the management of HIV infection.

  1999cites this paper
• Antiretroviral chemotherapy.

  1998cites this paper
• International AIDS Society – USA Topics in HIV Medicine 4 When to Begin

  year unknowncites this paper